Clinical Trial Update: Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the pharmacokinetics and elimination of Ethacrynic acid in patients with non-muscle-invasive bladder cancer undergoing transurethral re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• ETHACRYNIC ACID (Ethacrynic acid)

Snippet

Sponsor: Eugene Lee, MD | Conditions: Bladder Cancer | Phase 1 | Status: COMPLETED